Our latest press releases highlight the partnerships, research initiatives, and product innovations driving OMG Pharma’s vision for the future of natural therapies. Discover how we are advancing science-led solutions designed to elevate patient care and support healthcare professionals.
Oz Medicann Group and Macquarie University sign an exclusive global IP licence to develop natural medicine therapies for fungal infections…
Read releaseOMG Pharma begins a world-first NICM clinical study of a CBD topical salve for rheumatoid arthritis pain and inflammation…
Read releaseOMG Pharma wins the 2024 Cannabiz Award for Best Product Launch for its Unwind Topical Pain Relief Salve…
Read releaseOz Medicann Group launches asksam™, an AI-powered bot designed to support personalised patient care and streamline medical operations…
Read releaseOMG Pharma partners with dsm-firmenich on pharmaceutical-grade CBD for a phase 3 insomnia trial, advancing evidence-led sleep medicine…
Read releaseMedia enquiries: info@ozmedicann.com
